Mirae Asset Financial Group

GLOBAL X COMPLETES REBRAND FROM HORIZONS ETFS & ANNOUNCES UPCOMING PRODUCT LAUNCHES

Retrieved on: 
星期三, 五月 1, 2024
ETF, Final, Marketing, Partnership, Toronto Stock Exchange, Mirae Asset Financial Group, Name, Prospectus, Financial adviser

TORONTO, May 1, 2024 /CNW/ - Global X Investments Canada Inc. ("Global X" or the "Company") is pleased to announce that it has completed its rebrand (the "Rebrand") from Horizons ETFs, which was previously announced by press release on March 6, 2024 .

Key Points: 
  • TORONTO, May 1, 2024 /CNW/ - Global X Investments Canada Inc. ("Global X" or the "Company") is pleased to announce that it has completed its rebrand (the "Rebrand") from Horizons ETFs, which was previously announced by press release on March 6, 2024 .
  • "Now, as Global X, we're advancing that reputation by harnessing global strength and bringing an international bench of investment experts, technologies and products to the Canadian marketplace."
  • "We're thrilled to unveil our transition to Global X and mark our spot, where innovation meets investing in Canada," said Stephanie Wolfe, Executive Vice-President, Marketing of Global X.
  • Effective today, all of the Company's Horizons-branded exchange traded funds (the "Continuing ETFs") now reflect the Global X brand.

Global X ETFs Appoints Eric Olsen as Head of Finance

Retrieved on: 
星期五, 四月 12, 2024
Commodity, ETF, Mirae Asset Financial Group, HR, Risk management, Global X ETFs, Investment, AUM, Acquisition

NEW YORK, April 12, 2024 /PRNewswire/ -- Global X ETFs, the New York-based provider of exchange-traded funds (ETFs), today announced the appointment of Eric Olsen as the Global X ETFs Head of Finance, effective April 23, 2024. In addition, effective April 23, 2024, Mr. Olsen has been named Chief Financial Officer, Treasurer, and Principal Accounting Officer of the Global X Funds.

Key Points: 
  • NEW YORK, April 12, 2024 /PRNewswire/ -- Global X ETFs, the New York-based provider of exchange-traded funds (ETFs), today announced the appointment of Eric Olsen as the Global X ETFs Head of Finance, effective April 23, 2024.
  • In addition, effective April 23, 2024, Mr. Olsen has been named Chief Financial Officer, Treasurer, and Principal Accounting Officer of the Global X Funds.
  • Mr. Olsen, who previously served as Director, Investment Manager Services at SEI Investments, will be responsible for leading financial and HR functions at Global X.
  • Ryan O'Connor, CEO of Global X ETFs, commented, "During my first week here, it has already become clear how talented and energized the Global X team is, and we are thrilled to welcome Eric as our latest addition to that team.

Global X ETFs Appoints ETF and Financial Services Veteran Ryan O'Connor as Chief Executive Officer

Retrieved on: 
星期二, 二月 20, 2024
Mirae Asset Financial Group, Acquisition, USD, Risk management, Growth, ETF, AUM, Commodity

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Global X ETFs, the New York-based provider of exchange-traded funds (ETFs), today announced the appointment of Ryan O'Connor as its Chief Executive Officer effective as of April 8, 2024. 

Key Points: 
  • NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Global X ETFs, the New York-based provider of exchange-traded funds (ETFs), today announced the appointment of Ryan O'Connor as its Chief Executive Officer effective as of April 8, 2024.
  • It's our desire to take Global X from a rising star to a clear-cut leader in the ETF industry.
  • By doing so, Global X has renewed agility, a re-focus on its core competencies and a clear emphasis on its client base.
  • Ryan has a notable track record of driving growth across the ETF value chain for the world's largest asset managers.

Mirae Asset Capital Life Science Emerges from Stealth with $50M Fund

Retrieved on: 
星期四, 一月 18, 2024
Professional Services, Health, Finance, Clinical Trials, Research, Science, Biotechnology, Mirae Asset Financial Group, Master of Philosophy, Oncology, Patient, DSM-IV codes, LP, Multimedia, BioNTech, Drug discovery, Investment, Like a Boss (film), Therapy, Protein engineering, Lead, Growth, Pharmaceutical industry

Mirae Asset Capital Life Science , a venture capital firm investing in private biotechnology companies, has officially emerged from stealth with the announcement of its inaugural $50mn fund: Mirae Asset Capital Life Science Inception I, LP.

Key Points: 
  • Mirae Asset Capital Life Science , a venture capital firm investing in private biotechnology companies, has officially emerged from stealth with the announcement of its inaugural $50mn fund: Mirae Asset Capital Life Science Inception I, LP.
  • The firm is supported by a diverse global investor base comprised of Limited Partners within the Mirae Asset Financial Group .
  • View the full release here: https://www.businesswire.com/news/home/20240118292619/en/
    Naveen M. Krishnan, MD, MPhil is the Managing Director of Mirae Asset Capital Life Science and oversees the firm's investments, strategy, and growth.
  • Mirae Asset Capital Life Science distinguishes itself as the sole U.S. affiliate investing in life science within the Mirae Asset Financial Group.

Dental robotics leader Neocis secures $20M in funding

Retrieved on: 
星期三, 一月 10, 2024
Patient, Yomi, Quality of life, Dentistry, Food, FDA, Robotics, Mirae Asset Financial Group, Growth

MIAMI, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Neocis ®, the global leader in robot-assisted dental implant surgery, announced today that the company has raised $20M in additional funding.

Key Points: 
  • MIAMI, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Neocis ®, the global leader in robot-assisted dental implant surgery, announced today that the company has raised $20M in additional funding.
  • Headquartered in Miami, Neocis manufactures and markets Yomi ®, dentistry’s first and only robotic surgical system cleared by the U.S. Food and Drug Administration (FDA).
  • A dental implant is placed with Yomi approximately every six minutes, according to current data from Neocis.
  • “Neocis is transforming dental implant procedures, demonstrating the benefits of robotics and AI in healthcare.”
    To learn more about Neocis and the Yomi platform, visit neocis.com .

Global X Announces Leadership Change

Retrieved on: 
星期一, 十一月 20, 2023
ETF, AUM, Global X ETFs, Mirae Asset Financial Group

Thomas Park, the Co-Chief Executive Officer of Mirae Asset Global Investments (USA), an affiliate of the parent company of Global X, will lead the firm on an interim basis while it conducts a search for Luis' permanent replacement.

Key Points: 
  • Thomas Park, the Co-Chief Executive Officer of Mirae Asset Global Investments (USA), an affiliate of the parent company of Global X, will lead the firm on an interim basis while it conducts a search for Luis' permanent replacement.
  • Mr. Park has been a board member of Global X since Mirae Asset acquired the company in 2018.
  • Mr. Berruga joined Global X in 2014 as Chief Operating Officer and was named CEO in 2018.
  • Added Mr. Park, "On behalf of everyone at Global X and Mirae Asset, I want to thank Luis for his leadership and dedication to the firm.

Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics

Retrieved on: 
星期四, 九月 14, 2023
Health, Technology, Health Technology, Artificial Intelligence, Pharmaceutical, Biotechnology, Biomedicine, Asthma, Alpha generation platform, Probability, Drug development, University, Therapy, SARS-CoV-2, Infection, Enzyme, ARCH Venture Partners, COVID, Mirae Asset Financial Group, MD Anderson Cancer Center, Pandemic, Clinical trial, ADIA, Flagship Pioneering, Patient, Biology, Abu Dhabi Investment Office, Abu Dhabi Investment Authority, Disease, Pharmaceutical industry, Vaccine, Management, Amgen, Generate

Generate:Biomedicines, a clinical-stage biotherapeutics company pioneering a machine-learning-powered generative biology platform, today announced that it has raised $273 million in Series C financing.

Key Points: 
  • Generate:Biomedicines, a clinical-stage biotherapeutics company pioneering a machine-learning-powered generative biology platform, today announced that it has raised $273 million in Series C financing.
  • This financing round attracted many new investors including Amgen; NVentures, NVIDIA’s venture capital arm; MAPS Capital (Mirae Asset Group); and Pictet Alternative Advisors.
  • The company will leverage Series C funding to further its pipeline, including filing multiple INDs in 2024 and initiating multiple clinical trials annually thereafter.
  • Additionally, the company will fully validate the breadth of its platform capabilities and establish its leadership in de novo therapeutic development.

Ascend Elements Raises $542 Million to Accelerate Production of U.S.-engineered Lithium-Ion Battery Materials

Retrieved on: 
星期三, 九月 6, 2023
Hydro, Version One Ventures, EV, Mirae Asset Financial Group, CMA, Metal, QIA, CAM, Venture round, BIL, Carbon, DOE, Goldman Sachs, NMC, PULSE, JV, The Writing on the Wall, Tenaska, Temasek, Investment, Qatar Investment Authority, Element, United States Department of Energy, Security (finance), Cryptocurrency, Lithium, Renewable energy, Series

WESTBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Ascend Elements, a U.S.-based manufacturer of sustainable, engineered battery materials for electric vehicles, today announced it has raised $542 million in new equity investments, including $460 million in Series D investments and $82 million of additional investments from earlier this year. Ascend Elements' Series D round was led by Decarbonization Partners, Singapore-based investment firm Temasek, and Qatar Investment Authority (QIA). Other investors include Tenaska, Alliance Resource Partners, PULSE - CMA CGM Energy Fund, BHP Ventures, Fifth Wall, Hitachi Ventures, Mirae Asset, At One Ventures, Agave Partners, Alumni Ventures and other leading global investors.

Key Points: 
  • Ascend Elements' Series D round was led by Decarbonization Partners , Singapore-based investment firm Temasek , and Qatar Investment Authority (QIA).
  • The $542 million equity financing is one of the largest cleantech private placements in the United States of 2023.
  • Our sustainable lithium-ion battery materials will power EV batteries and accelerate the global transition to zero carbon emissions," said CEO Mike O'Kronley of Ascend Elements.
  • Several peer-reviewed studies have shown Ascend Elements' recycled battery materials perform as well as similar materials made from virgin (or mined) sources while reducing carbon emissions by up to 93%.

Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted Medicines

Retrieved on: 
星期二, 七月 11, 2023
Science, Biotechnology, Research, Pharmaceutical, Finance, Health, Professional Services, Clinical Trials, Seizure, Kidney failure, Drug development, Therapy, Venture round, G protein-coupled receptor, Goldman Sachs, Arrhythmia, Hypoparathyroidism, Lead, Brain, PTH, Fatigue, Muscle weakness, Richard Driehaus, Protein, GPCR, Third Rock Ventures, Patient, Mirae Asset Financial Group, PTH1R, Parathyroid hormone, TSHR, Pharmaceutical industry

Septerna , a biotechnology company discovering and advancing novel oral small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced the closing of a $150 million Series B financing.

Key Points: 
  • Septerna , a biotechnology company discovering and advancing novel oral small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced the closing of a $150 million Series B financing.
  • In conjunction with the financing, Jake Simson, Ph.D., partner at RA Capital Management, will join Septerna’s board of directors.
  • This is an exciting time for GPCR drug development, and we are eager to move our novel products toward clinical development.
  • Septerna is focused on developing a first-in-class, oral small molecule PTH1R agonist designed to treat all patients with hypoparathyroidism.

OpenInfra Foundation Welcomes Okestro as First Gold Member in South Korea

Retrieved on: 
星期二, 六月 13, 2023
Cloud, DevOps, SK Telecom, Contrabass, Workforce, Platform as a service, Infrastructure as a service, Meta, Huawei, SDDC, Artificial Intelligence for IT Operations, NIRS, OpenStack, Samsung, Microsoft, Deutsche Telekom, Ericsson, Mirae Asset Financial Group, Unilateral Declaration of Egyptian Independence, Silver, Security, CMP, Korea, Bloomberg, Ubuntu, Gold, South Korea, Red Hat, National Pension Service, Ant Group, United Nations Information and Communication Technologies Task Force, K Bank, Naver, Growth, Architecture, AI, Bank, ZTE, NEC, Video game, Network equipment provider, China Telecom, Viola

VANCOUVER, Canada, June 13, 2023 /PRNewswire-PRWeb/ -- OPENINFRA SUMMIT — The Open Infrastructure Foundation (OpenInfra Foundation) announced today that Okestro has elevated its commitment to the global community by becoming a Gold Member after joining a year ago as a Silver Member. Okestro is also Premier Sponsor of the OpenInfra Summit.

Key Points: 
  • As a leading cloud software company in South Korea, Okestro pledges to encourage adoption of OpenInfra technology, elevating South Korea as a leader in the global cloud ecosystem.
  • VANCOUVER, Canada, June 13, 2023 /PRNewswire-PRWeb/ -- OPENINFRA SUMMIT — The Open Infrastructure Foundation (OpenInfra Foundation) announced today that Okestro has elevated its commitment to the global community by becoming a Gold Member after joining a year ago as a Silver Member.
  • Other Okestro clients in South Korea include the National Pension Service, 'H' Financial Group, 'K' Bank and the National Ministry of Defense.
  • To support this growth and priorities of the community in South Korea, Okestro is a founding participant of OpenInfra Asia , a regional hub announced at the OpenInfra Summit Vancouver today.